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BACKGROUND AND PURPOSE
Although the stoichiometry of the major synaptic αβγ subunit-containing GABAA receptors has consensus support for
2α:2β:1γ, a clear view of the stoichiometry of extrasynaptic receptors containing δ subunits has remained elusive.
Here we examine the subunit stoichiometry of recombinant α4β3δ receptors using a reporter mutation and a functional
electrophysiological approach.
EXPERIMENTAL APPROACH
Using site-directed mutagenesis, we inserted a highly characterized 9′ serine to leucine mutation into the second
transmembrane (M2) region of α4, β3 and δ subunits that increases receptor sensitivity to GABA. Whole-cell, GABA-activated
currents were recorded from HEK-293 cells co-expressing different combinations of wild-type (WT) and/or mutant α4(L297S),
β3(L284S) and δ(L288S) subunits.
KEY RESULTS
Recombinant receptors containing one or more mutant subunits showed increased GABA sensitivity relative to WT receptors
by approximately fourfold, independent of the subunit class (α, β or δ) carrying the mutation. GABA dose–response curves of
cells co-expressing WT subunits with their respective L9′S mutants exhibited multiple components, with the number of
discernible components enabling a subunit stoichiometry of 2α, 2β and 1δ to be deduced for α4β3δ receptors. Varying the
cDNA transfection ratio by 10-fold had no significant effect on the number of incorporated δ subunits.
CONCLUSIONS AND IMPLICATIONS
Subunit stoichiometry is an important determinant of GABAA receptor function and pharmacology, and δ subunit-containing
receptors are important mediators of tonic inhibition in several brain regions. Here we demonstrate a preferred subunit
stoichiometry for α4β3δ receptors of 2α, 2β and 1δ.
Abbreviations
M2, second transmembrane region; nAChRs, nicotinic acetylcholine receptors; PTX, picrotoxin; SA, spontaneous
channel activity; WT, wild-type
Introduction
GABAA receptors are the main class of inhibitory ligand-gated
ion channels in the mammalian CNS (receptor nomenclature
follows Alexander et al., 2013). They are hetero-pentameric
complexes forming a central anion-conducting channel. To
date, eight classes of GABAA receptor subunits have been
identified, with half of these exhibiting multiple isoforms:
α(1–6), β(1–3), γ(1–3), δ, ε, θ, π and ρ(1–3). Although GABAA
receptors exhibit distinct regional and developmental expres-
sion patterns in the CNS, γ2-containing receptors are consid-
ered the dominant subtype found at GABAergic inhibitory
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synapses (Somogyi et al., 1996). By contrast, δ-containing
receptors are thought to be exclusively found at extrasynaptic
sites, where they play an important role in mediating tonic
inhibition (Farrant and Nusser, 2005). Extrasynaptic α4βδ
receptors have been identified in several neuronal cell types,
including dentate gyrus granule cells and thalamic relay
neurons (Sur et al., 1999; Peng et al., 2002). In addition, extra-
synaptic α6δ and α1δ pairs have been identified in cerebellar
granule cells (Jones et al., 1997) and hippocampal inter-
neurons (Glykys et al., 2007), respectively, together with
extrasynaptic α5βγ and α1β assemblies identified in the hip-
pocampus (Mortensen and Smart, 2006; Glykys et al., 2008).
The subunit composition of GABAA receptors is an impor-
tant determinant of their functional properties as demon-
strated by the type of α subunit and presence of the γ2
subunit affecting, for example, receptor sensitivity to benzo-
diazepines (Korpi et al., 2002). Given that orthosteric and
many allosteric binding sites on GABAA receptors are interfa-
cial (Sieghart et al., 2012), it becomes important to under-
stand whether there are preferred subunit stoichiometries
that will critically define the nature of these subunit inter-
faces and thus the receptor’s response to ligand binding.
Compared with αβγ receptors, we know least about δ subunit-
containing GABAA receptors, which play an important role
mediating tonic inhibition in several brain regions (Brickley
et al., 2001; Porcello et al., 2003; Farrant and Nusser, 2005;
Santhakumar et al., 2010). To address this deficit, we have
employed a pharmacological analysis, in combination with a
reporter mutation, to better understand the structural prop-
erties of δ-containing receptors using heterologous expression
systems (e.g. HEK-293 and Xenopus laevis oocytes). Previous
reports note that some functional discrepancies have been
observed for αβδ receptors, such as EC50 values for GABA and
ethanol sensitivity (Wallner et al., 2003), which have been
postulated to arise, in part, from differences in subunit stoi-
chiometry (Borghese et al., 2006; Wagoner and Czajkowski,
2010). Although the stoichiometry of major synaptic αβγ
GABAA receptor isoforms has broad consensus support for
2α:2β:1γ (Backus et al., 1993; Chang et al., 1996; Tretter et al.,
1997), an unequivocal view of the stoichiometry for extras-
ynaptic δ-containing receptors remains elusive. Although
atomic force microscopy of recombinant α4β3δ receptors has
suggested a stoichiometry of 2α:2β:1δ (Barrera et al., 2008),
biochemical analysis of recombinant α4β2δ receptors indi-
cates that more than one δ can be incorporated into the
receptor complex (Wagoner and Czajkowski, 2010). Moreo-
ver, it was recently demonstrated on the basis of using α1β3δ
(Kaur et al., 2009) and α6β3δ concatemers (Baur et al., 2009)
that more than one δ subunit can be incorporated into func-
tional channels, although for the former subtype, a con-
strained conformation of 2α:2β:1δ most closely resembled the
pharmacological profile of unconstrained recombinant α1β3δ
receptors (Kaur et al., 2009).
In this study, we have examined the subunit stoichiom-
etry of functional recombinant α4β3δ receptors, utilizing
polar substitutions of a highly conserved leucine residue
within the second transmembrane region (M2) of GABAA
receptors. This residue exchange acts as a reporter mutation
causing a profound increase in agonist potency consequently
displacing the agonist dose–response curve (Chang et al.,
1996; Chang and Weiss, 1999), as also observed for nicotinic
ACh receptors (nAChRs) (Filatov and White, 1995; Labarca
et al., 1995) and 5-HT3 receptors (Yakel et al., 1993). The
extent of the curve shift is correlated with the number of
polar substitutions per ion channel complex, and this has
been used to deduce the subunit stoichiometry of recombi-
nant α1β2γ2 GABAA receptors (Chang et al., 1996). By insert-
ing this highly characterized 9′ serine to leucine (L9′S)
mutation into α4, β3 and δ subunits, we derive a subunit
stoichiometry of 2α:2β:1δ for functional α4β3δ GABAA recep-
tors. Furthermore, our data indicate that for three different,
but commonly used, cDNA transfection ratios, the number of
incorporated δ subunits seemingly remains fixed at one.
Methods
Site-directed mutagenesis
Inverse PCR was used to introduce the M2 leucine-to-serine
substitutions into murine α4 and β3, and rat δ subunits. The
δ subunit was tagged at the N-terminus (between residues 13
and 14 of the mature protein) with a super ecliptic phluorin.
The mutagenic oligonucleotides used to make α4(L297S),
β3(L284S) and δ(L288S) were 5′-CACGATGACCACCCTAAG
CATC-3′ (sense), 5′-CCACCATGACAACCATCAACACTC-3′
(sense) and 5′- CGACAATGACCACACTCATGGTTA-3′ (sense)
respectively. Successful mutations were verified by full DNA
sequencing.
Transient receptor expression in
HEK-293 cells
HEK-293 cells were cultured in DMEM supplemented with
10% v/v fetal calf serum, 2 mM glutamine, 100 u·mL−1 peni-
cillin G and 100 μg·mL−1 streptomycin, and were incubated at
37°C in humidified 95% air and 5% CO2. HEK cells were
plated on poly-L-lysine-coated coverslips and transfected
using a calcium phosphate protocol. Briefly, cDNA encoding
wild-type (WT) and/or mutant α4, β3 and δ subunits, in
transfection ratios of 1:1:1, 1:1:10 or 10:1:10, were mixed
with 340 mM CaCl2, and an equal volume of HBSS (50 mM
HEPES, 280 mM NaCl and 2.8 mM Na2HPO4, pH 7.2) to form
a precipitate. The total amount of cDNA used for each trans-
fection was 4 μg. The DNA–calcium phosphate suspension
was applied to HEK cells, which were incubated overnight,
and used for electrophysiology 16–24 h after transfection. For
the co-expression experiments, WT subunits and their respec-
tive L9′S mutants were co-expressed in equal amounts, with
an overall transfection ratio remaining at 10α:1β:10δ.
Electrophysiological recordings
Transfected HEK cells were placed in a recording chamber and
viewed with a Nikon Diaphot microscope (Nikon, Kingston-
upon-Thames, UK) and phase contrast optics. Cells were con-
tinuously perfused with Krebs solution containing (in mM)
140.0 NaCl, 4.7 KCl, 1.2 MgCl2, 2.52 CaCl2, 11.0 glucose and
5.0 HEPES, adjusted to pH 7.4 with 1 M NaOH. Patch pipettes
were fire polished to 2–4 MΩ and filled with an intracellular
solution containing (in mM) 120 KCl, 1 MgCl2, 11 EGTA, 10
HEPES, 1 CaCl2 and 2 ATP, adjusted to pH 7.2 with 1 MNaOH.
Whole-cell agonist-activated currents were recorded with
an Axopatch 200B amplifier (Molecular Devices, Sunnyvale,
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CA, USA). Cells were voltage clamped between −20 and
−60 mV, depending on peak current size. Whole-cell currents
were filtered at 5 kHz (−36 dB), digitized at 50 kHz via a Digi-
data 1332A (Molecular Devices) and recorded to disk (Dell
Pentium Dual Core Optiplex 960; Dell, Berks, UK). Series
resistances were monitored throughout each experiment and
deviations >20% resulted in the data being excluded from
further analysis.
Data analysis
Currents (IGABA) activated by concentrations of GABA ([A])
were normalized to the maximal current caused by a saturat-
ing concentration of GABA (IMax,GABA). The normalized
concentration–response curves were fitted with the following
equation using a non-linear least-squares method:
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where EC50 is the GABA concentration inducing a half-
maximal current, n is the nH, i is the number of components
where j = 1 – 3.
For WT α4β3 and α4β3δ receptors, the level of inhibition
exhibited by 1 μM Zn2+ on GABA EC50 responses for each
receptor subtype was also assessed.
The spontaneous channel activity exhibited by each
mutant was calculated by expressing the outward current
induced by the blocker picrotoxin (IPTX; 1 mM) as a percent-
age of the maximum current, defined as the sum of IMax,GABA
and IPTX. No spontaneous activity (SA) was observed for WT
α4β3δ receptors. The level of SA was quantified according to:
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I
I I
%
,
( ) =
+
PTX
PTX Max GABA
All data are expressed as mean ± SEM. Where appropriate,
statistical analyses were performed using an unpaired Stu-
dent’s t-test or a one-way ANOVA.
Materials
GABA (Sigma, Dorset, UK) and zinc chloride (BDH Biochemi-
cal, Poole, UK) solutions were prepared from 1 M stocks (in
water), whereas 1 mM picrotoxin (Sigma) was dissolved in
extracellular Krebs solution containing 0.05% v/v dimethyl
sulfoxide (Sigma). Drugs were applied via a U-tube applica-
tion system (Mortensen and Smart, 2007).
Results
Functional expression of WT and L9′S
mutant α4, β3 and δ subunits
The highly conserved 9′ leucine residues in α4, β3 and δ
subunits (Figure 1) were mutated to serines, producing
α4(L297S), β3(L284S) and δ(L288S). These mutated subunits
are referred to as αm, βm and δm, whereas their WT counter-
parts are designated as α, β and δ. WT αβδ, and mutant αβδm,
αmβδ and αβmδ-expressing cells (Figure 2A), demonstrated a
dose-dependent sensitivity to GABA (Figure 2A). Notably,
GABA whole-cell currents of mutant subunit-expressing cells
exhibited prolonged deactivation phases compared with
those for WT αβδ receptors (Figure 2A).
With regard to channel gating αβδm, αmβδ and αβmδ, but
not αβδ receptors, exhibited spontaneous activation in the
absence of exogenously applied GABA, which was blocked by
the chloride channel blocker, picrotoxin (1 mM; Figure 2B).
Expressed as a proportion of the total GABA-activated plus
spontaneous current [IPTX/(IPTX + IMax,GABA; Figure 2B inset)], the
levels of spontaneous receptor activation for αmβδ and αβδm
receptors were 21.9 ± 5.3 and 16 ± 1% respectively. The
highest level of spontaneous activation was exhibited by
αβmδ-expressing cells (76.6 ± 6.5%) relative to αβδm (P < 0.001)
and αmβδ (P < 0.05) receptors (non-parametric ANOVA –
Kruskal–Wallis test). The increased degree of spontaneous
receptor activation observed for the β mutant is likely to
reflect the predominant role this subunit plays in stabilizing
open-shut GABA channel conformation(s). It is also notewor-
thy that β homomers can form spontaneously opening ion
channels (Krishek et al., 1996; Davies et al., 1997; Wooltorton
et al., 1997; Cestari et al., 2000) unlike their α, γ or δ subunit
counterparts.
Both the SA and distinctive deactivation profiles exhib-
ited by mutant subunit-expressing cells confirmed that each
mutant was efficiently co-assembled into functional αβδ
receptors.
L9′S mutations in α4, β3 and δ subunits
increase GABA sensitivity
By compiling GABA dose–response curves for cells expressing
the subunit combinations, αβδ, αβδm, αmβδ, αβmδ and αmβδm,
those containing δm, αm or βm subunits exhibited an increased
GABA sensitivity compared with WT αβδ receptors, manifest
by a leftward shift in the curves for mutant receptor-
expressing cells (Figure 3A). Whereas WT αβδ receptors had a
GABA EC50 of 1.91 ± 0.47 μM, single mutant subunit-
containing receptors possessed lower EC50 values of 0.46 ±
0.11 μM (αβδm), 0.12 ± 0.03 μM (αmβδ) and 0.11 ± 0.04 μM
(αβmδ; Table 1). Notably, the nH obtained for αβmδ receptors
(0.63 ± 0.06; Table 1) was significantly lower than those
obtained for αβδm (1.41 ± 0.12) and αmβδ (1.18 ± 0.19) recep-
tors (Welch’s t-test: P = 0.02 and P = 0.03 respectively).
Although we cannot simply transpose the change in nH to any
physical attribute, it is possible that the L9′S mutations
altered the gating kinetics of the receptor, which may account
for the changes in nH. Moreover, the effects on gating kinetics
may be highly dependent on the subunit in which the muta-
tion is inserted.
Figure 1
Primary sequence alignment of the second transmembrane region
(M2) of α4, β3 and δ subunits. Prime notation (red) denotes the
amino acids comprising the ion channel pore. The conserved hydro-
phobic 9′ leucine residues are indicated and boxed for α4, β3 and δ
subunits, with their numbering in the mature subunit proteins.
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The αβδm receptors exhibited an approximately fourfold
(4.15) increase in GABA sensitivity, relative to αβδ receptors.
The increased sensitivity of αβδm was not attributable to a
large population of αβ receptors being expressed as the EC50
for αβ receptors (1.01 ± 0.13 μM; data not shown) is similar to
that for αβδ receptors (1.91 ± 0.47 μM; Welch’s t-test: P =
0.13). By comparison, the GABA sensitivities of αmβδ and
αβmδ receptors were higher compared with δm-containing
receptors, causing shifts of 16 (15.91) and 17 (17.36)-fold,
respectively, in the GABA EC50 (Figure 3).
If we assume each subunit mutation has an equivalent
effect on GABA potency, independent of the subunit class in
which the L9′S mutation is inserted, and if we further assume
that the receptor contains two α subunits, then we would
expect the shift in EC50 by the 9′ mutation to be approxi-
mately the square of the change due to a single α subunit.
Thus a shift of 15.91 predicts a single α subunit would cause
a 3.99-fold change in EC50. Similarly for the β subunit, a
17.36-fold shift indicates each β subunit (if two copies are
present in the receptor) should cause a 4.17-fold change.
These are equivalent to that caused by the δ subunit (4.15)
and the findings therefore suggest that relative to the δ
subunit, twice the number of α4 and β3 subunits are likely to
exist in each receptor complex. Thus, because GABAA recep-
tors are assumed to form pentameric complexes, αmβδ, αβmδ
and αβδm probably contained 2αm, 2βm and 1δm subunits.
Increasing GABA sensitivity with the number
of co-assembled L9′S mutant subunits
For heteromeric muscle nAChRs, each 9′ polar substitution
within the ion channel confers an additional ∼10-fold
Figure 2
Functional expression of WT and L9′S mutant α4, β3 and δ subunits.
In this and subsequent figures, WT α4, β3 and δ subunits are labelled
as α, β and δ, whereas mutated α4(L297S), β3(L284S) and δ(L288S)
subunits are designated as αm, βm and δm. (A) Examples of whole-cell
currents elicited by increasing concentrations of GABA on HEK cells
expressing recombinant αβδ, αβδm, αmβδ and αβmδ receptors. A
transfection ratio of 10α:1β:10δ was used. Note the increased GABA
sensitivity and prolonged deactivation kinetics exhibited by mutant-
expressing cells. (B) Bar graph of SA for αβδ, αβδm, αmβδ, αβmδ and
αmβδm receptors. Values were calculated by expressing the outward
current induced by the Cl− channel blocker picrotoxin (IPTX; 1 mM) as
a percentage of the maximum current, defined as the sum of IMax,GABA
and IPTX (n = 4–11; mean ± SEM). No SA (= 0%) was observed for WT
α4β3δ receptors. The inset shows example GABA-activated and
picrotoxin-sensitive currents (IMax,GABA and IPTX) for αβδ and αβδm
receptors. Current calibration bars: 300 pA (αβδ); 400 pA (αβδm).
Figure 3
L9′S mutations in α4, β3 and δ subunits increase GABA sensitivity. (A)
GABA concentration–response curves for αβδ, αβδm, αmβδ, αβmδ and
αmβδm receptors. Data represent the mean ± SEM from n = 5–9. Each
data set was fitted to the Hill equation (continuous lines) using a
non-linear least-squares method. Parameters from these fits are pro-
vided in Table 1. (B) Relationship between the number of mutant
receptors incorporated into the receptor pentamer (assuming a stoi-
chiometry of 2α:2β:1δ) and the average GABA EC50 values.
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increase in agonist sensitivity (Filatov and White, 1995;
Labarca et al., 1995). However, such a linear relationship has
not been observed for recombinant α1β2γ2S GABAA receptors
(Chang and Weiss, 1999), where mutations in α, β and γ
subunits contributed unequally to the increased GABA sensi-
tivity, thus prohibiting an estimate of receptor stoichiometry
(Chang and Weiss, 1999). By contrast, for our α, β and δ
subunit receptors, the shifts appeared more consistent, with
each mutation contributing an approximately fourfold
increase in GABA sensitivity. We therefore investigated the
relationship between GABA potency and the number of
mutant substitutions in δ-containing GABAA receptors with
αmβδm-expressing cells.
Based on our predictions, αmβδm receptors would be
expected to contain three mutant subunits (i.e. two αs and
one δ), and thus exhibit even greater sensitivity to GABA,
than either αmβδ (double mutant) or αβδm (single mutant)
receptors.
For αmβδm receptors an EC50 of 0.08 ± 0.02 μM (Table 1)
was determined, which equates to a 23.87-fold increase in
GABA sensitivity, which is greater than that for αmβδ and
αβmδ receptors and approximates to a threefold shift (2.88)
per mutant subunit. Based on the double mutant receptors,
we predicted an approximately fourfold shift per subunit, and
thus for three mutant subunits, we might have expected
a 64-fold increase in GABA sensitivity. The discrepancy
between the predicted and actual shift observed for αmβδm
could arise from the δm subunit being absent from αmβδm
receptor-expressing cells, leaving cell surface receptors mainly
composed of αβ receptors containing just two mutant αm
subunits. However, this seemed unlikely given that for αmβδm-
expressing cells, there was clear evidence of cell surface
δm–GFP fluorescence. Furthermore, αmβδm-expressing cells
exhibited a level of SA (49.4 ± 8.4%) that was comparable
with the combined spontaneous activities of αmβδ (21.9 ±
5.3%) and αβδm receptors (15.7 ± 1.3%; Figure 2B). Taken
together, these data suggest that both αm and δm subunits
were efficiently incorporated into functional αmβδm receptors.
Our predicted shift of 64-fold for αmβδm receptors was predi-
cated on the assumption that each additional mutant subunit
within the receptor complex acts independently. Although
this holds for receptors with two mutant subunits, it is con-
ceivable that with three such substitutions, some degree of
interaction between adjacent mutant subunits might cause
deviations from the predicted curve shifts.
cDNA transfection ratio has no effect on
α4β3δ receptor stoichiometry
Recently, using an imaging approach based on inserting bun-
garotoxin binding sites into GABAA receptor subunits that
could be subsequently labelled by fluorescent bungarotoxin,
it was demonstrated that the number of δ subunits incorpo-
rated into the α4β2δ receptor complex could vary with the
cDNA transfection ratio (Wagoner and Czajkowski, 2010). We
therefore investigated this possibility using our functional
approach with HEK cells transfected with one of the follow-
ing three commonly used α : β : δ cDNA ratios – 1:1:1, 1:1:10
or 10:1:10 (Borghese et al., 2006; Stórustovu and Ebert, 2006;
Barrera et al., 2008; Hoestgaard-Jensen et al., 2010).
First, we ascertained the sensitivity of αβδ-expressing cells
to the GABAA receptor subtype–selective blocker Zn2+ (Smart
et al., 1991; Nagaya and Macdonald, 2001; Hosie et al., 2003)
to assess if binary αβ constructs were present as 1 μM Zn2+
selectively inhibits αβ to a far greater extent than αβδ recep-
tors (Krishek et al., 1998; Hosie et al., 2003; Stórustovu and
Ebert, 2006). Accordingly, 1 μM Zn2+ inhibited the GABA EC50
response of αβ receptors by 75.5 ± 5.7% (Figure 4A). By con-
trast, the Zn2+ sensitivity of αβδ-expressing cells did not vary
significantly with the αβδ transfection ratio (13.1 ± 3.4,
17.0 ± 3.9 and 17.6 ± 0.7%; one-way ANOVA – Bonferroni:
P = 0.5), but all were significantly reduced compared with
Zn2+ inhibition of αβ receptors (Figure 4A; one-way ANOVA –
Dunnett’s: P < 0.0001). These data also confirmed the likeli-
hood of efficient incorporation of δ subunits into functional
αβδ receptors, for all three transfection ratios used.
We next studied the effect of varying the transfection
ratio on GABA sensitivities of αβδ and αβδm receptors. For WT
αβδ receptors, altering the transfection ratio had no effect on
GABA sensitivity (1.38 ± 0.20, 1.88 ± 0.32 and 1.91 ± 0.47 μM
for αβδ ratios of 1:1:1, 1:1:10 and 10:1:10, respectively; one-
way ANOVA – Bonferroni: P = 0.56). Similarly, the GABA dose–
response curves for αβδm-expressing cells transfected with
different ratios were also indistinguishable (Figure 4B), and
their GABA EC50 values (0.23 ± 0.01, 0.31 ± 0.08 and 0.46 ±
0.11 μM for αβδm ratios of 1:1:1, 1:1:10 and 10:1:10, respec-
tively) did not differ significantly (one-way ANOVA – Bonfer-
roni: P = 0.20). Although there appears to be a trend for
αβδm-expressing cells transfected with a 10:1:10 ratio to have
higher nH (1.4 ± 0.2; Figure 4B) than those transfected with
either a 1:1:1 (0.82 ± 0.03) or 1:1:10 (0.9 ± 0.2) transfection
ratio, this was not significant (Welch’s t-test: P = 0.09 and
P = 0.17 respectively).
Overall, altering the transfection ratio had no significant
effect on the relative GABA EC50 shifts between δ- and
δm-expressing cells (Figure 4B), suggesting that at least for
these three transfection ratios, the number of δ subunits
incorporated into α4β3δ receptors remains relatively
constant.
Table 1
GABA concentration–response curve parameters for WT and L9′S
mutant containing αβδ receptors
Subunit
combination
GABA EC50
(μM) nH
No. of
mutants*
αβδ 1.91 ± 0.47 1.06 ± 0.04 0
αβδm 0.46 ± 0.11 1.41 ± 0.12 1
αβmδ 0.11 ± 0.04 0.63 ± 0.06 2
αmβδ 0.12 ± 0.03 1.18 ± 0.19 2
αmβδm 0.08 ± 0.02 0.95 ± 0.07 3
*Number of mutants within the pentamer assuming a 2α:2β:1δ
stoichiometry. GABA dose–response curves were obtained from
five to nine HEK cells expressing αβδ, αβδm, αβmδ, αmβδ or αmβδm
receptors. The Hill equation was fitted to each data set, and the
mean values for GABA potency (EC50) and the Hill slope (nH) are
shown in the table as mean ± SEM.
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Co-expressing WT and mutant subunits
confirms α4β3δ receptor stoichiometry
Our deductions so far are based on the assumption that each
subunit mutation has an equivalent effect on GABA potency,
regardless of the subunit in which the L9′S mutation is
inserted. Although this holds for our α4β3δ receptors, some
deviation may occur when the number of mutant subunits
per receptor is increased, as noted for α1β2γ2S GABAA recep-
tors (Chang et al., 1996) and heteromeric nAChRs (Labarca
et al., 1995). To overcome this methodological limitation,
Chang et al. (1996) proposed an alternative approach for
deducing subunit stoichiometry that does not rely on the
relative EC50 shifts induced by different classes of mutant
subunits, but instead relied on co-expressing WT and L9′S
mutants to generate multiple populations of receptors
expressed in the same cells (Chang et al., 1996).
In principle, the co-expression of WT subunits with their
respective L9′S mutants (e.g. α and αm) should introduce
discrete and discernible components into the GABA dose–
response curve of expressing cells. For example, assuming
there are two α subunits per receptor pentamer, these com-
ponents would represent distinct GABAA receptors of ααβδ,
αmαmβδ and ααmβδ and its equivalent, αmαβδ. Thus, the GABA
sensitivity that is attributable to an individual receptor popu-
lation would be observed by an inflection in the dose–
response curve. This analysis was used to infer the subunit
stoichiometry for α1β2γ2S GABAA receptors (Chang et al.,
1996).
Taking a similar approach for α4β3δ receptors, we gener-
ated GABA dose–response curves for cells co-transfected with
β, δ and equal amounts of α and αm cDNAs. The ααmβδ GABA
dose–response curve exhibited three discernible components,
which were described by the sum of three Hill equations
(Figure 5A). The first and third components accounted for
34.0 ± 3.3 and 17.5 ± 2.7% of the total receptor population,
with GABA EC50 values of 0.023 ± 0.005 and 5.72 ± 0.90 μM
respectively (Table 2). These EC50 values are in close proxim-
ity to those for αmβδ (0.46 ± 0.11 μM) and αβδ (1.9 ± 0.47 μM)
receptors, suggesting these two components to the dose–
response curves of ααmβδ (Figure 5A) are attributable to αmβδ
and αβδ receptors. Moreover, the appearance of an interme-
diary component with an EC50 of 0.30 ± 0.03 μM (48.7 ±
5.6%) suggested the expression of receptor pentamers con-
taining one WT and one mutant subunit (i.e. ααmβδ or
αmαβδ). Similar to ααmβδ-expressing cells, the GABA dose–
response curves of αββmδ-expressing cells revealed three dis-
tinct components (Figure 5B). The first component (24.7 ±
3.5%) had an EC50 of 0.03 ± 0.01 μM, corresponding to the
αβmδ receptor population. Approximately 31.5 ± 2.6% of
receptors exhibited an EC50 of 4.68 ± 0.74 μM attributable to
αβδ receptors. Again, the appearance of an intermediary com-
ponent with an EC50 of 0.31 ± 0.05 μM (43.9 ± 3.5%) was
indicative of a third receptor population containing both β
subtypes (i.e. β and βm).
By contrast, the mean GABA dose–response curve for
αβδδm receptors did not exhibit obvious multiple components
(Figure 5C). However, detailed analysis of individual dose–
response curves revealed that for most cells sampled (7/10),
two components were discerned (Figure 5C inset). For those
cells exhibiting two components, the majority of receptors
(75.8 ± 3.0%) exhibited a GABA EC50 of 0.21 ± 0.01 μM,
whereas 24.2 ± 2.8% of receptors exhibited an EC50 of 2.14 ±
0.48 μM. The GABA sensitivities of these two components are
similar to the observed EC50s for αβδm and αβδ receptors
respectively (Table 2). Although the remaining cells (3/10)
did not overtly display multiple components, their GABA
sensitivities were intermediary to those of αβδ- and αβδm-
expressing cells. The absence of a third component suggested
that αβδδm-expressing cells exhibit only two receptor popu-
lations, αβδ and αβδm, and thus it follows that each receptor
complex is most likely to contain only one δ subunit.
Collectively, these data demonstrate that αβδ receptors
are most likely to contain two αs, two βs and one δ subunit.
Figure 4
cDNA transfection ratio has no effect on α4β3δ receptor stoichiom-
etry. (A) Inhibition by 1 μM Zn2+ of GABA EC50 currents for αβ or αβδ
receptors expressed following transfection with one of three α:β:δ
cDNA ratios: 1:1:1, 1:1:10 and 10:1:10 (n = 4–5; mean ± SEM). The
total amount of cDNA used for each transfection was 4 μg. (B) GABA
concentration–response curves for αβδ (filled circles) or αβδm (open
circles) transfected with the α:β:δ cDNA ratios: 1:1:1, 1:1:10 and
10:1:10. The Hill equation was fitted to each data set using a non-
linear least-squares method (continuous lines).
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Discussion
Although the stoichiometry of synaptic α1β2γ2 subunit-
containing GABAA receptors has consensus support for
2α:2β:1γ (Backus et al., 1993; Chang et al., 1996; Tretter et al.,
1997), the stoichiometry of extrasynaptic δ-containing
receptors remains unclear and potentially variable with a
dependence on experimental conditions. This may reflect a
difference in the co-assembly properties of δ , with different α
and β subunits (Baur et al., 2009; Kaur et al., 2009; Wagoner
and Czajkowski, 2010). We used an alternative approach
to probe α4β3δ stoichiometry by introducing a well-
characterized 9′ leucine-to-serine mutation into the M2
domains of α4, β3 and δ subunits. Each polar substitution
increased the GABA sensitivity of mutant subunit-containing
receptors (by approximately fourfold) in relative proportion
with the number of mutant subunits assembled in the
receptor. This, in conjunction with data derived from cells
co-expressing mutant and respective WT subunits, revealed
a relatively consistent subunit stoichiometry, by these
methods, of 2α, 2β and 1δ.
Assumptions and limitations
Our deductions regarding α4β3δ GABAA receptor stoichiom-
etry are predicated on the assumption that the L9′S muta-
tions do not perturb the ‘normal’ subunit stoichiometry
of these receptors. Because N-terminal motifs have been
established as the key determinants of GABAA receptor
subunit assembly (Connolly et al., 1996; Taylor et al., 1999;
Klausberger et al., 2001), it seemed unlikely that a point
mutation within the ion channel-lining M2 region would
alter receptor subunit stoichiometry. However, it is intriguing
that for most αβδδm-expressing cells, the component that was
attributable to αβδm receptors was larger than that for αβδ
receptors (∼75 and 24%, respectively), suggesting that δm
might be more efficiently incorporated into functional recep-
tors than δ.
Given the M2 location of the point mutation, a more
likely explanation for the disproportionate percentage com-
ponents is that the mutation may affect the gating kinetics of
the receptor. For nAChRs (Filatov and White, 1995) and
GABAA α1β3γ2L receptors (Bianchi and Macdonald, 2001), it
has been demonstrated that 9′ mutant-containing receptors
can exhibit altered single-channel conductances and/or open
probabilities. This could cause the apparent percentage com-
ponents of αβδ and αβδm to vary (Chang et al., 1996). Never-
theless, because our conclusions rely on the number of
observable components in the dose–response curves and not
on the relative contribution of each individual component,
our conclusion that α4β3δ receptors contain only one δ
subunit still remains valid.
Comparison with previous studies
To date, only two studies have investigated the subunit stoi-
chiometry of unconstrained recombinant α4β2/3δ receptors.
Although atomic force microscopy has revealed a subunit
stoichiometry of 2α4:2β3:1δ (Barrera et al., 2008), the immu-
nopurification of cell surface α4β2δ receptors suggested that
by increasing the relative abundance of δ, more than one δ
can be incorporated into the receptor complex (Wagoner and
Figure 5
Co-expression of WT and mutant L9′S α4, β3 and δ subunits. GABA
concentration–response curves (black continuous lines) for (A)
ααmβδ (n = 6), (B) αββmδ (n = 6) and (C) αβδδm (n = 10), fitted using
a two or three component Hill equation (see Methods section). Also
shown for each receptor class are the Hill equation fits for the GABA
concentration–response curves of WT αβδ receptors (blue dashed
lines) and their respective L9′S mutants (red dashed lines): αmβδ (A),
αβmδ (B) and αβδm (C). For αβδδm, the GABA dose–response curves of
7/10 cells exhibited two discernible components. The inset is an
example of GABA dose–response curve from a cell exhibiting two
such components. The total amount of cDNA used for each trans-
fection was 4 μg, and equal amounts of WT and their respective L9′S
mutant cDNA were used. Data points are shown as mean ± SEM.
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Czajkowski, 2010). Moreover, a study using receptor expres-
sion in oocytes reported that increasing relative amounts of δ
cRNA increased the GABA EC50 and decreased the Hill slopes
for α4β3δ GABA dose–response curves (You and Dunn, 2007).
Although a change in stoichiometry may account for
altered receptor function, it is also equally plausible, from
studies using concatemers and thus constrained subunit posi-
tions, that δ subunits may assume various locations within a
functional receptor pentamer, and also potentially contribute
to an agonist-binding site (Kaur et al., 2009; Sigel et al., 2009).
Thus the previously described effects on receptor function
may also have arisen from the rearrangement of subunits
within the receptor. Indeed, for concatemeric α1β3δ recep-
tors, those with an βαβαδ (anticlockwise) subunit arrange-
ment appear to be ∼26-fold less sensitive to GABA than
receptors with the βαβδα (anticlockwise) subunit arrange-
ment (Kaur et al., 2009), demonstrating the functional impor-
tance of subunit location within a receptor pentamer.
Our data indicate that, at least for three commonly used
α : β : δ transfection ratios 1:1:1, 1:1:10 or 10:1:10 (Borghese
et al., 2006; Stórustovu and Ebert, 2006; Barrera et al., 2008;
Hoestgaard-Jensen et al., 2010), the number of incorporated δ
subunits seemingly remains fixed at one. Moreover, we found
no significant effect of altering cDNA transfection ratio on
α4β3δ receptor function. In accordance with our findings,
another oocyte study had demonstrated no significant effect
of altering cRNA transfection ratio on the sensitivity of WT
α4β3δ receptors to GABA or Zn2+ (Borghese and Harris, 2007).
Although the discrepancy between our observations and
those previously reported remain unclear, one difference may
be the use of different expression systems. Alternatively, the
use of different β isoforms may also give rise to these discrep-
ancies. Given that β2 and β3 subunits have been demon-
strated to have distinctive assembly properties (Taylor et al.,
1999), this might have important implications for their oli-
gomerization with δ subunits.
Subunit positioning
Although we demonstrate a stoichiometry of 2α:2β:1δ for
α4β3δ receptors, our data give little indication of subunit
arrangement, which could be an important determinant of
αβδ receptor function (Baur et al., 2009; Kaur et al., 2009).
The subunit positional arrangement of α1βγ2 receptors is
widely accepted to be βαβαγ (anticlockwise) (Baumann et al.,
2001; 2002; Baur et al., 2006; Smart and Paoletti, 2012).
Given the conflicting evidence regarding the number of
incorporated δ subunits, it is unsurprising that the subunit
arrangement of recombinant αβδ remains undefined. For
α4β3δ receptors with a stoichiometry of 2α:2β:1δ, structural
microscopic analysis has revealed a predominant βαβαδ anti-
clockwise arrangement (Barrera et al., 2008), suggesting δ can
assume the position of the γ2 subunit in an αβγ receptor.
However, in the same study, a minority of receptors (∼21%)
were found to have an alternative βαβδα subunit arrange-
ment, indicating more than one arrangement may be possi-
ble (Barrera et al., 2008). Indeed it has been recently
demonstrated that δ can assume multiple positions when
constrained within αβδ concatemers (Baur et al., 2009; Kaur
et al., 2009). Intriguingly, concatemeric α4β2δ receptors with
the βαβαδ conformation (Shu et al., 2012) form functional
receptors with similar pharmacological profiles to uncon-
strained recombinant α4β2δ receptors (Stórustovu and Ebert,
2006), whereas α1β3δ receptors formed from the alternative
βαβδα anticlockwise arrangement exhibit similar GABA and
Zn2+ sensitivities to non-concatenated receptors (Kaur et al.,
2009). These findings suggest that the arrangement of
recombinant and native δ-containing receptors is still open to
question.
To conclude, we demonstrate that the subunit stoichiom-
etry of heterologously expressed α4β3δ receptors is 2α:2β:1δ.
This stoichiometry remains unchanged even with varying
cDNA transfection ratios, which may reflect that this is the
preferred, dominant subunit assembly for this important
extrasynaptic GABAA receptor subtype that underlies tonic
inhibition in some areas of the brain.
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Table 2
GABA concentration–response curve components for WT and L9′S mutant containing αβδ receptors
Receptor
subunits
First component Second component Third component
nH
EC50
(μM)
Proportion
%
EC50
(μM)
Proportion
%
EC50
(μM)
Proportion
%
ααmβδ 0.023 ± 0.005 34.0 ± 3.3 0.30 ± 0.03 48.7 ± 5.6 5.72 ± 0.90 17.5 ± 2.7 1.58 ± 0.36
αββmδ 0.03 ± 0.01 24.7 ± 3.5 0.31 ± 0.05 43.9 ± 3.5 4.68 ± 0.74 31.5 ± 2.6 2.06 ± 0.31
αβδδm 0.21 ± 0.01 75.8 ± 3.0 – – 2.14 ± 0.48 24.2 ± 2.8 0.94 ± 0.09
GABA concentration–response curve parameters derived from curve fitting data from 6 to 10 HEK cells expressing ααmβδ, αββmδ or αβδδm.
Individual cells expressing ααmβδ, αββmδ or αβδδm were fitted using a two or three component Hill equation. The relative component
proportions (%) and GABA EC50 values are expressed as mean ± SEM. Cells were transfected with a cDNA transfection ratio of 10:1:10.
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